SCHEMBL7090981

SCHEMBL7090981

[CH2]Cc1csc(NS(=O)(=O)c2cccc(Cl)c2C)n1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 9/20 0.67
HSD17B1 P14061 2/20 0.67
HSD17B2 P37059 2/20 0.67
KDM1A O60341 2/20 0.47
MAOA P21397 2/20 0.47
SLC40A1 Q9NP59 1/20 0.47
EDNRB P24530 2/20 0.47
EDNRA P25101 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
CCR4 P51679 1/20 0.45
ALDH1A1 P00352 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5911779 0.89 HSD11B1 (0.72) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL4963665 0.89 HSD11B1 (0.69) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL4966355 0.88 HSD11B1 (0.70) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL3602689 0.87 HSD11B1 (0.66) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL5911680 0.87 HSD11B1 (0.69) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL3612077 0.86 HSD11B1 (0.68) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL3614770 0.86 HSD11B1 (0.65) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL4965432 0.86 HSD11B1 (0.68) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL3619881 0.86 HSD11B1 (0.65) HSD11B1HSD17B1HSD17B2KDM1AMAOA
SCHEMBL3612714 0.85 HSD11B1 (0.76) HSD11B1HSD17B1HSD17B2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019075394-A1 COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME VANDERKLISH PETER (US) 2019-04-18 WO disclosed
EP-1283831-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2003-02-19 EP disclosed
WO-2001090090-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2001-11-29 WO disclosed